Institutional investors hold a majority ownership of ARNA through the 60.39% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended September 2017, these large investors purchased a net $205.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MONEGA KAPITALANLAGEGESELLSCHAFT... Bought 5.0 Thousand shares of Arena Pharmaceuticals Inc
KLP KAPITALFORVALTNING AS Bought 1.5 Thousand shares of Arena Pharmaceuticals Inc